Patients of African heritage have fewer actionable mutations
Drug Discovery World
APRIL 17, 2023
Genomic profiling of patients who were treated for colorectal cancer showed that patients with African ancestry had fewer actionable mutations than patients with European ancestry. However, the extent to which differences in germline or somatic genomic alterations influence outcomes remains unknown.”
52 
Let's personalize your content